Areas of Expertise: Cancer biology
Hussein joined Anglia Ruskin University in November 2018 where he worked as a research fellow. Hussein’s research focuses on assessing the efficacy of anticancer treatment in several cancer types including breast, lung, colorectal, ovarian and pancreatic cancers. Hussein is now a lecturer and deputy course leader in MSc Applied Bioscience.
Prior to working at ARU, Hussein held the position of a research fellow at Brunel University London and had investigated how defects in DNA repair contribute to controlling the response to anticancer therapy. Hussein also utilised imaging flow cytometry to identify and enumerate circulating tumour cells in patients’ blood.
Hussein is now a lecturer in Biomedical Science and the deputy course leader in MSc Applied Bioscience at ARU. His research now revolves around evaluating the efficacy of novel antibodies in treating a variety of cancers and identifying the mechanism of cell kill in collaboration with commercial investors.
Module Leader for Undergraduate Project
Module Leader for Molecular Genetics and Bioinformatics
Module Leader for Contemporary Medical Diagnostics
Deputy Course Leader for MSc Applied Biosciences
Bourton, E. C., Ahorner, P. A., Plowman, P. N., Zahir, S. A., Al-Ali, H., Parris, C. N., 2017. The PARP-1 inhibitor Olaparib suppresses BRCA1 protein levels, increases apoptosis and causes radiation hypersensitivity in BRCA1+/- lymphoblastoid cells. Journal of Cancer, 23(19), pp. 4048-4056.
Parris, C. N., Adam-Zahir, S., Al-Ali, H., Bourton, E. C., Plowman, C., Plowman, P. N., 2015. Enhanced γ-H2AX DNA damage foci detection using multi-magnification and extended depth of field in imaging flow cytometry. Journal of Cytometry, Part A, 87(8), pp. 717-23.